OncoSil Medical Ltd (AU:OSL) has released an update.
OncoSil Medical Ltd has announced the issuance of 75 million unquoted options, expiring on June 30, 2025, at an exercise price of $0.009 each, effective from June 24, 2024. These securities, part of a transaction previously communicated to the market, will not be quoted on the ASX. The announcement indicates a notable increase in the company’s potential equity, which could be of interest to investors tracking unquoted securities.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.
